Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06651801
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-07
Brief Title:
Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Pilot Randomized Controlled Trial Assessing the Feasibility and Acceptability of Group Medical Visits for Anxiety and Depression
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this clinical trial is to evaluate the feasibility and acceptability of the intervention Group Medical Visits GMVs for patients with depression and anxiety It also aims to get some initial information on the effectiveness of GMVs on reducing depression and anxiety scores which will help inform power calculations for a future larger randomized controlled trial RCT The main question it aims to answer is
Are GMVs feasible and acceptable to patients with depression and anxiety
This study consists of a pilot RCT with an intervention and control arm At enrollment participants will be randomized to the intervention group 6 months of GMVs or to the control group which consists of standard client services For the GMV group participants will engage in a biweekly virtual group that is similar to a standard psychiatric follow-up Participants in the control group will receive standard care after a psychiatric assessment which includes follow-up with their primary care provider family physician or nurse practitioner individual psychiatric care if suggested by the psychiatrist who did their psychiatric assessment andor a referral to publicly funded therapy groups if interested
Are GMVs feasible and acceptable to patients with depression and anxiety
This study consists of a pilot RCT with an intervention and control arm At enrollment participants will be randomized to the intervention group 6 months of GMVs or to the control group which consists of standard client services For the GMV group participants will engage in a biweekly virtual group that is similar to a standard psychiatric follow-up Participants in the control group will receive standard care after a psychiatric assessment which includes follow-up with their primary care provider family physician or nurse practitioner individual psychiatric care if suggested by the psychiatrist who did their psychiatric assessment andor a referral to publicly funded therapy groups if interested
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None